Clinical trial
Neurobiological Analyses Within the FORESEE III Study
NCT04021823 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neurobiological Analyses Within the FORESEE III Study
- Lead sponsor
- University Hospital Freiburg
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 1, 2019
- Completion date
- June 30, 2023
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
treatment resistant depression